首页> 外文OA文献 >Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing
【2h】

Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing

机译:肱骨近端骨折愈合过程中核因子-kB可溶性受体激活剂(sRANK),核因子-kB配体可溶性受体激活剂(sRANKL)和骨保护素(OPG)的血浆和排泄液水平

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fracture healing is an ordered process that restores the structural integrity of the bone. Soluble receptor activator of nuclear factor-kB (sRANK), its ligand (sRANKL) and osteoprotegerin (OPG) are involved in bone remodelling, thus they may play a role in fracture repair. OPG, soluble RANK and RANKL levels were measured in plasma and in drainage fluid, collected from pre-surgery phase to healing in ten patients of both genders (age range 26–65 years) with proximal humerus fracture needing osteosynthesis. All patients showed fracture healing. No significant modifications in the concentrations of sRANKL and OPG were observed, while sRANK showed a significant increase in drainage fluid 24 hours post-surgery compared with intra-surgery time. OPG levels were higher in plasma and drainage fluid than sRANK and sRANKL at each time point. Since there are no published data about sRANK involvement in fracture healing, our study represents the first preliminary indication about a local increase of this marker concentration immediately after surgery.
机译:骨折愈合是有序的过程,可恢复骨骼的结构完整性。核因子-kB的可溶性受体激活剂(sRANK),其配体(sRANKL)和骨保护素(OPG)参与骨重塑,因此它们可能在骨折修复中发挥作用。从术前到康复期的10名男女(年龄范围26-65岁)伴有肱骨近端骨折的肱骨患者,从血浆中和血浆中测量OPG,可溶性RANK和RANKL的水平,从术前到治愈。所有患者均显示骨折愈合。没有观察到sRANKL和OPG浓度的显着变化,而sRANK显示与手术时间相比,术后24小时引流液显着增加。在每个时间点,血浆和引流液中的OPG水平均高于sRANK和sRANKL。由于尚无有关sRANK参与骨折愈合的数据,我们的研究代表了手术后即刻局部增加该标志物浓度的第一个初步迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号